Connect public, paid and private patent data with Google Patents Public Datasets

Stabilisierte Formulierungen mit kontrollierter Abgabe mit einem Acrylpolymerüberzug

Info

Publication number
DE69230028T2
DE69230028T2 DE1992630028 DE69230028T DE69230028T2 DE 69230028 T2 DE69230028 T2 DE 69230028T2 DE 1992630028 DE1992630028 DE 1992630028 DE 69230028 T DE69230028 T DE 69230028T DE 69230028 T2 DE69230028 T2 DE 69230028T2
Authority
DE
Grant status
Grant
Patent type
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE1992630028
Other languages
English (en)
Other versions
DE69230028D1 (de )
DE69230028T3 (de )
Inventor
Benjamin Oshlack
Mark Chasin
Frank Pedi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Euroceltique SA
Original Assignee
Euroceltique SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date
Family has litigation

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/284Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846Poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DE1992630028 1992-01-27 1992-08-03 Methode um eine stabilisierte Formulierung mit kontrollierter Abgabe mit einem Acrylpolymerüberzug zu erhalten Expired - Lifetime DE69230028T3 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US07826084 US5286493A (en) 1992-01-27 1992-01-27 Stabilized controlled release formulations having acrylic polymer coating
US826084 1997-03-24

Publications (2)

Publication Number Publication Date
DE69230028T2 true DE69230028T2 (de) 2000-04-13
DE69230028T3 DE69230028T3 (de) 2008-05-21

Family

ID=25245664

Family Applications (2)

Application Number Title Priority Date Filing Date
DE1992630028 Expired - Lifetime DE69230028T3 (de) 1992-01-27 1992-08-03 Methode um eine stabilisierte Formulierung mit kontrollierter Abgabe mit einem Acrylpolymerüberzug zu erhalten
DE1992630028 Expired - Lifetime DE69230028D1 (de) 1992-01-27 1992-08-03 Stabilisierte Formulierungen mit kontrollierter Abgabe mit einem Acrylpolymerüberzug

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1992630028 Expired - Lifetime DE69230028D1 (de) 1992-01-27 1992-08-03 Stabilisierte Formulierungen mit kontrollierter Abgabe mit einem Acrylpolymerüberzug

Country Status (8)

Country Link
US (1) US5286493A (de)
JP (1) JP3957329B2 (de)
CA (1) CA2074309C (de)
DE (2) DE69230028T3 (de)
DK (1) DK0553392T4 (de)
EP (1) EP0553392B2 (de)
ES (1) ES2141713T5 (de)
RU (1) RU2127587C1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034308A1 (de) * 2009-07-21 2011-02-03 Winkelmann, Wolfgang, Dr. Medizinisches Präparat zur Behandlung von entzündlichen Prozessen

Families Citing this family (168)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
EP0590060B1 (de) * 1991-06-21 1997-09-17 University Of Cincinnati Oral verabreichbare therapeutische proteine und herstellungsverfahren
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
US7740881B1 (en) * 1993-07-01 2010-06-22 Purdue Pharma Lp Method of treating humans with opioid formulations having extended controlled release
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
DE4310012A1 (de) * 1993-03-27 1994-09-29 Roehm Gmbh Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
DK0699436T4 (da) 1993-05-10 2013-04-08 Euro Celtique Sa Præparat med reguleret frigivelse
US5849240A (en) * 1993-11-23 1998-12-15 Euro-Celtique, S.A. Method of preparing sustained release pharmaceutical compositions
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
EP2263673A1 (de) * 1993-07-01 2010-12-22 Euro-Celtique S.A. Opioidformulierungen mit verlängerter gesteuerter Wirkstoffabgabe
US5879705A (en) * 1993-07-27 1999-03-09 Euro-Celtique S.A. Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5773025A (en) * 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
EP2036558A3 (de) * 1993-10-07 2010-04-28 Euro-Celtique S.A. Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
US5914131A (en) * 1994-07-07 1999-06-22 Alza Corporation Hydromorphone therapy
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
DE19531684A1 (de) * 1995-08-29 1997-03-06 Bayer Ag Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
GB9519363D0 (en) 1995-09-22 1995-11-22 Euro Celtique Sa Pharmaceutical formulation
ES2322405T3 (es) 1996-07-08 2009-06-19 Penwest Pharmaceuticals Co. Matriz de liberacion controlada para farmacos insolubles en dosis elevadas.
JPH1050306A (ja) * 1996-07-31 1998-02-20 Toyota Autom Loom Works Ltd 水素吸蔵合金電極の製造方法
DK0951280T3 (da) * 1996-10-03 2004-05-17 Hermes Biosciences Inc Hydrofile mikropartikler og fremgangsmåder til fremstilling heraf
WO1999001111A1 (en) 1997-07-02 1999-01-14 Euro-Celtique, S.A. Stabilized sustained release tramadol formulations
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
US20040029962A1 (en) * 1997-12-12 2004-02-12 Chih-Ming Chen HMG-COA reductase inhibitor extended release formulation
DK1041987T3 (da) 1997-12-22 2006-08-21 Euro Celtique Sa Oral farmaceutisk doseringsform omfattende en kombination af en opioid-agonist og naltrexon
US6228863B1 (en) * 1997-12-22 2001-05-08 Euro-Celtique S.A. Method of preventing abuse of opioid dosage forms
DE19808634A1 (de) 1998-02-24 1999-08-26 Schering Ag Mantel für eine pharmazeutische Zusammensetzung
US6471975B1 (en) 1998-05-01 2002-10-29 3M Innovative Properties Company Microspheres as a delivery vehicle for bio-active agents useful in agricultural applications
US7354596B1 (en) 1998-05-01 2008-04-08 3M Innovative Properties Company Anti-microbial agent delivery system
US6312728B1 (en) * 1998-07-07 2001-11-06 Cascade Development, Inc. Sustained release pharmaceutical preparation
US20020006438A1 (en) * 1998-09-25 2002-01-17 Benjamin Oshlack Sustained release hydromorphone formulations exhibiting bimodal characteristics
US6806294B2 (en) 1998-10-15 2004-10-19 Euro-Celtique S.A. Opioid analgesic
US7083808B2 (en) * 1998-12-17 2006-08-01 Euro-Celtique S.A. Controlled/modified release oral methylphenidate formulations
US6673367B1 (en) 1998-12-17 2004-01-06 Euro-Celtique, S.A. Controlled/modified release oral methylphenidate formulations
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US6270807B1 (en) 1999-03-02 2001-08-07 L. Perrigo Company Taste-masked pharmaceutical composition
FR2794646B1 (fr) 1999-06-09 2001-09-21 Ethypharm Lab Prod Ethiques Microgranules de sulfate de morphine, procede de preparation et composition les contenant
US6565877B1 (en) 1999-06-11 2003-05-20 Ranbaxy Laboratories Limited Taste masked compositions
US7030097B1 (en) * 1999-07-14 2006-04-18 Cornell Research Foundation, Inc. Controlled nucleic acid delivery systems
EP1135106B1 (de) * 1999-09-30 2008-04-09 Penwest Pharmaceuticals Co. Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
RU2230556C2 (ru) * 1999-10-29 2004-06-20 Эро-Селтик, С.А. Препаративные формы гидрокодона с контролируемым высвобождением
ES2312413T3 (es) 2000-02-08 2009-03-01 Euro-Celtique S.A. Composiciones de liberacion controlada que contienen un agonista y antagonista de opioide.
ES2415407T3 (es) * 2000-02-08 2013-07-25 Euro-Celtique S.A. Formulaciones orales de agonistas opioides resistentes a manipulaciones indebidas
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
JP2004512354A (ja) 2000-10-30 2004-04-22 ユーロ−セルティーク,エス.エイ. ヒドロコドン放出制御製剤
US20040172169A1 (en) * 2001-03-02 2004-09-02 Curtis Wright Method and apparatus for compouding individualized dosege forms
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DK2281555T3 (da) * 2001-05-02 2016-06-06 Euro-Celtique S A Oxycodonformuleringer til administration én gang dagligt
CA2446550C (en) 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
CN100356907C (zh) * 2001-06-08 2007-12-26 恩德制药公司 利用丙烯酸酯聚合物的控释剂型和其制备方法
WO2003007802A3 (en) * 2001-07-18 2003-11-27 Christopher D Breder Pharmaceutical combinations of oxycodone and naloxone
US20030157168A1 (en) * 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
US20030044458A1 (en) * 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
WO2003013525A1 (en) 2001-08-06 2003-02-20 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
EP1429728A1 (de) * 2001-08-29 2004-06-23 SRL Technologies, Inc. Zubereitungen mit verzögerter freisetzung
DK1439829T3 (da) * 2001-10-24 2005-10-10 Gruenenthal Gmbh Lægemiddel indeholdende 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol med forsinket frigivelse af det aktive stof
EP2339328A3 (de) 2002-12-30 2011-07-13 Transform Pharmaceuticals, Inc. Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
US8183290B2 (en) * 2002-12-30 2012-05-22 Mcneil-Ppc, Inc. Pharmaceutically acceptable propylene glycol solvate of naproxen
US7927613B2 (en) * 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20090088443A1 (en) * 2002-02-15 2009-04-02 Julius Remenar Novel crystalline forms of conazoles and methods of making and using the same
US7790905B2 (en) * 2002-02-15 2010-09-07 Mcneil-Ppc, Inc. Pharmaceutical propylene glycol solvate compositions
US20100311701A1 (en) * 2002-02-15 2010-12-09 Transform Pharmaceuticals, Inc Pharmaceutical Co-Crystal Compositions
CA2477923A1 (en) * 2002-03-01 2003-09-12 University Of South Florida Multiple-component solid phases containing at least one active pharmaceutical ingredient
EP2319496A1 (de) 2002-04-05 2011-05-11 Euro-Celtique S.A. Pharmazeutische Zubereitung enthaltend Oxycodon und Naloxon
EP1515703A1 (de) 2002-06-21 2005-03-23 Transform Pharmaceuticals, Inc. Pharmazeutische zusammensetzungen mit verbesserter auflösung
ES2358151T3 (es) 2002-08-15 2011-05-06 Euro-Celtique S.A. Composiciones farmacéuticas que comprenden un antagonista opioide.
WO2004026235A3 (en) * 2002-09-20 2004-08-05 Om Almarsson Pharmaceutical compositions with improved dissolution
US20050020613A1 (en) * 2002-09-20 2005-01-27 Alpharma, Inc. Sustained release opioid formulations and method of use
WO2004026283A1 (en) * 2002-09-20 2004-04-01 Alpharma, Inc. Sequestering subunit and related compositions and metohds
DE60320039D1 (de) * 2002-10-25 2008-05-08 Labopharm Inc Tramadol-formulierungen mit verzögerter freisetzung und 24-stunden-wirksamkeit
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US20060148877A1 (en) * 2002-11-26 2006-07-06 Transform Pharmaceuticals, Inc. Pharmaceutical formulations of celcoxib
EP2218448B1 (de) 2002-12-13 2015-09-23 Durect Corporation Orale Darreichungsform mit flüssigen hochviskose Trägersystemen
US20040202717A1 (en) * 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
ES2341546T3 (es) 2003-04-21 2010-06-22 Euro-Celtique S.A. Productos resistentes a la manipulacion indebida para el aporte de opioides.
ES2490598T3 (es) * 2003-06-27 2014-09-04 Euro-Celtique S.A. Multiparticulados
US20060165790A1 (en) * 2003-06-27 2006-07-27 Malcolm Walden Multiparticulates
US20050048118A1 (en) * 2003-07-25 2005-03-03 Joan Cucala Escoi Modified release venlafaxine hydrochloride tablets
EP1663229B1 (de) 2003-09-25 2010-04-14 Euro-Celtique S.A. Pharmazeutische kombinationen von hydrocodon und naltrexon
KR20060120049A (ko) * 2003-09-26 2006-11-24 알자 코포레이션 오피오이드 및 비오피오이드 진통제의 제어 방출 제제
CN1897924B (zh) 2003-09-26 2011-09-21 阿尔扎公司 能提供高载药量的药物包衣和提供它的方法
JP2007506775A (ja) * 2003-09-26 2007-03-22 アルザ・コーポレーシヨン 漸増する放出速度を表す制御放出製剤
CA2540047A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Oros push-stick for controlled delivery of active agents
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050084540A1 (en) * 2003-10-17 2005-04-21 Indranil Nandi Taste masking antibiotic composition
EP1691811B1 (de) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Kombination aus einem sedativum und einem neurotransmitter-modulator und verfahren zur verbesserung der schlafqualität und zur behandlung von depression
US20050152969A1 (en) * 2004-01-08 2005-07-14 Chiprich Timothy B. Colored liquid-filled soft capsules and method of manufacture thereof
EP3228308A1 (de) * 2005-01-28 2017-10-11 Euro-Celtique S.A. Alkoholresistente darreichungsformen
DE602005026786D1 (de) * 2004-03-30 2011-04-21 Euro Celtique Sa Verfahren zur herstellung von oxycodonhydrochlorid mit weniger als 25 ppm 14-hydroxycodeinon
EP1604666A1 (de) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
EP1604667A1 (de) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioide zur Behandlung des Restless Leg Syndroms
US7776358B2 (en) * 2004-07-22 2010-08-17 Synthon Ip Inc. Extended release venlafaxine besylate tablets
DE102004035938A1 (de) * 2004-07-23 2006-02-16 Röhm GmbH & Co. KG Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
GB2418854B (en) 2004-08-31 2009-12-23 Euro Celtique Sa Multiparticulates
EP1786404A2 (de) * 2004-09-01 2007-05-23 Euro-Celtique S.A. Opioid-dosierformen mit steady-state-cave proportional zur dosierung und auc und einzeldosen-cmax geringer als proportional zur dosierung
WO2006090845A1 (ja) * 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited 顆粒の製造方法
EP1695700A1 (de) * 2005-02-28 2006-08-30 Euro-Celtique S.A. Darreichungsform enthaltend Oxycodon und Naloxon
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
EP1877461B1 (de) * 2005-03-24 2009-05-06 Medtronic, Inc. Modifizierung von thermoplastischen polymeren
RU2008113439A (ru) * 2005-09-09 2009-10-20 Лабофарм Инк. (CA) Композиции с замедленным высвобождением лекарственного средства
FR2894143B1 (fr) * 2005-12-01 2008-05-02 Pierre Fabre Medicament Sa Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
EP1813276A1 (de) * 2006-01-27 2007-08-01 Euro-Celtique S.A. Manipulationssichere Dosierformen
JP2009526096A (ja) * 2006-02-07 2009-07-16 エフ エム シー コーポレーションFmc Corporation 徐放性被覆をつくるためのコーティング方法
US20070190141A1 (en) * 2006-02-16 2007-08-16 Aaron Dely Extended release opiate composition
KR101495146B1 (ko) 2006-03-16 2015-02-24 트리스 파마 인코포레이티드 약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
US20070281016A1 (en) * 2006-06-06 2007-12-06 Endo Pharmaceuticals Inc., A Delaware Corporation Sustained release oxycodone composition with acrylic polymer and surfactant
US20070286900A1 (en) * 2006-06-09 2007-12-13 Catherine Herry Low dose tablets of opioid analgesics and preparation process
ES2636657T3 (es) * 2006-06-19 2017-10-06 Alpharma Pharmaceuticals Llc Composición farmacéutica
CN101534792B (zh) 2006-08-04 2013-02-20 爱的发 包含氧可酮的粒剂和口腔崩解片剂
EP2292229B1 (de) 2006-08-25 2012-05-23 Purdue Pharma LP Manipulationssichere orale pharmazeutische Dosierformen enthaltend ein Opiatanalgetikum
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
GB0624880D0 (en) * 2006-12-14 2007-01-24 Johnson Matthey Plc Improved method for making analgesics
JP2008024708A (ja) * 2007-08-20 2008-02-07 Euro-Celtique Sa アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
EP2057984B1 (de) 2007-11-09 2010-01-20 Acino Pharma AG Retardtabletten mit Hydromorphon
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
US8623418B2 (en) * 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
EP2224808A4 (de) * 2007-12-17 2013-11-27 Alpharma Pharmaceuticals Llc Pharmazeutische zusammensetzung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
JP5406288B2 (ja) * 2008-07-07 2014-02-05 ユーロ−セルティーク エス.エイ. 尿閉を治療するためのオピオイド拮抗薬の使用
CA2736899C (en) 2008-09-25 2016-08-30 Isp Investments Inc. Smooth, high solids tablet coating composition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
US20100151014A1 (en) * 2008-12-16 2010-06-17 Alpharma Pharmaceuticals, Llc Pharmaceutical composition
CA2754853C (en) 2009-03-10 2015-04-28 Euro-Celtique S.A. Immediate release pharmaceutical compositions comprising oxycodone and naloxone
US8811578B2 (en) * 2009-03-23 2014-08-19 Telemanager Technologies, Inc. System and method for providing local interactive voice response services
JP2013526523A (ja) 2010-05-11 2013-06-24 シマ ラブス インク. メトプロロールを含むアルコール耐性持続放出性経口剤形
CN101987083B (zh) * 2010-07-16 2012-12-12 钟术光 一种控释制剂特别是零级释放的控释制剂制备方法
CN102018962B (zh) * 2010-07-16 2013-11-06 钟术光 在控释制剂中的聚合物增强剂
US8623409B1 (en) 2010-10-20 2014-01-07 Tris Pharma Inc. Clonidine formulation
EP2446882B8 (de) 2010-10-28 2014-02-12 Acino Pharma AG Arzneimittel mit dem Wirkstoff Hydromorphon mit verbesserter Lagerstabilität
WO2012080833A3 (en) 2010-12-13 2012-09-07 Purdue Pharma L.P. Controlled release dosage forms
ES2643291T3 (es) 2010-12-22 2017-11-22 Purdue Pharma L.P. Formas de dosificación de liberación controlada con cierre inviolable recubiertas
CA2822769C (en) 2010-12-23 2016-10-04 Purdue Pharma L.P. Tamper resistant solid oral dosage forms
JP5146859B2 (ja) * 2011-07-11 2013-02-20 ユーロ−セルティーク エス.エイ. アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
US8946253B2 (en) 2012-04-17 2015-02-03 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
CA2974010A1 (en) 2012-07-16 2014-01-23 Rhodes Technologies Process for improved opioid synthesis
CN104507947B (zh) 2012-07-16 2017-06-27 罗德科技公司 用于改进的阿片样物质合成的方法
JP6208261B2 (ja) 2013-02-05 2017-10-04 パーデュー、ファーマ、リミテッド、パートナーシップPurdue Pharma L.P. タンパリング抵抗性医薬製剤
US20140271896A1 (en) 2013-03-15 2014-09-18 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
US9572885B2 (en) 2013-03-15 2017-02-21 Durect Corporation Compositions with a rheological modifier to reduce dissolution variability
EP3027622A1 (de) 2013-08-02 2016-06-08 Johnson Matthey Public Limited Company Verfahren zur herstellung von oxymorphon
WO2015107471A1 (en) 2014-01-15 2015-07-23 Rhodes Technologies Process for improved oxycodone synthesis
JP6244035B2 (ja) 2014-01-15 2017-12-06 ローズ テクノロジーズ 改良されたオキシモルホン合成のための方法
US9062063B1 (en) 2014-03-21 2015-06-23 Johnson Matthey Public Limited Company Forms of oxymorphone hydrochloride
US9849124B2 (en) 2014-10-17 2017-12-26 Purdue Pharma L.P. Systems and methods for treating an opioid-induced adverse pharmacodynamic response
US20160220560A1 (en) 2015-01-29 2016-08-04 Johnson Matthey Public Limited Company Process of preparing low abuk oxymorphone hydrochloride
WO2017049185A1 (en) * 2015-09-17 2017-03-23 Ahmad Syed Taymur Process for protecting an electronic device by selective deposition of polymer coatings
US9861629B1 (en) 2015-10-07 2018-01-09 Banner Life Sciences Llc Opioid abuse deterrent dosage forms

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60166608A (en) * 1984-02-08 1985-08-29 Japan Atom Energy Res Inst Slow-releasing composite having sandwich structure and its preparation
US4600645A (en) * 1985-01-31 1986-07-15 Warner-Lambert Company Process for treating dosage forms
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
US5068110A (en) * 1987-09-29 1991-11-26 Warner-Lambert Company Stabilization of enteric coated dosage form
US5019397A (en) * 1988-04-21 1991-05-28 Alza Corporation Aqueous emulsion for pharmaceutical dosage form
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009034308A1 (de) * 2009-07-21 2011-02-03 Winkelmann, Wolfgang, Dr. Medizinisches Präparat zur Behandlung von entzündlichen Prozessen

Also Published As

Publication number Publication date Type
ES2141713T3 (es) 2000-04-01 grant
JP3957329B2 (ja) 2007-08-15 grant
RU2127587C1 (ru) 1999-03-20 grant
DK0553392T3 (da) 2000-03-06 grant
EP0553392B2 (de) 2007-12-05 grant
US5286493A (en) 1994-02-15 grant
DE69230028D1 (de) 1999-10-28 grant
ES2141713T5 (es) 2008-05-16 grant
CA2074309A1 (en) 1993-07-28 application
EP0553392B1 (de) 1999-09-22 grant
EP0553392A1 (de) 1993-08-04 application
DK0553392T4 (da) 2008-03-03 grant
JPH05201856A (ja) 1993-08-10 application
DE69230028T3 (de) 2008-05-21 grant
CA2074309C (en) 1999-11-23 grant

Similar Documents

Publication Publication Date Title
DE69322822T2 (de) Konische Linsenmontur mit Einschnapp-Klemmvorrichtung
DE9314162U1 (de) Regelbares Einspritz-System
DE69601473T2 (de) Kapillardosiereinrichtung mit einem Endschlitz
DE9208862U1 (de) Karabinerhaken
DE69425435T2 (de) Pulverbeschichtungssystem
DE69306706T2 (de) Optischer Wandler
DE69132441T2 (de) Ladungsträgerstrahlgerät
DE69318856T2 (de) Beschichtete Formkörper
DE69231450T2 (de) Polymere Oberflächenbeschichtungszusammensetzung
DE69332081T2 (de) Hydrogelzubereitung mit verzögerter freisetzung
DE9218502U1 (de) Schraubstift
DE69221826T2 (de) Aufgetragene Mikrokugeln
DE69422797T2 (de) Beschichtetes Verbindungsstück
DE69329808T2 (de) Pulverbeschichtung
DE69331346T2 (de) Verbinder hoher Packungsdichte
DE69319686T2 (de) Antiseptisches Polymer
DE69301984T2 (de) Das Beschlagen verhindernde Beschichtung
DE69301091T2 (de) Mit polyalkylenenimin oder polyallylamin überzogenes material
DE69321479T2 (de) Retinol enthaltende kosmetische zusammensetzung
DE9410082U1 (de) Malkoffer
DE69606471T2 (de) Düsenadapter mit Rezirkulationsventil
DE69327269T2 (de) Kosmetische Zusammensetzung
DE69324869T2 (de) Vielfachlasersystem mit schmaler Bandbreite
DE69320892T2 (de) Bildkamera
DE69306413T2 (de) Aufzugsmachinerie mit reibungsbremse